Access the full text.
Sign up today, get DeepDyve free for 14 days.
E. Hannan, Chuntao Wu, G. Walford, A. Culliford, J. Gold, Craig Smith, R. Higgins, Russell Carlson, Robert Jones (2008)
Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease.The New England journal of medicine, 358 4
A. Grüntzig (1978)
TRANSLUMINAL DILATATION OF CORONARY-ARTERY STENOSISThe Lancet, 311
F. Masoudi, R. Brindis, W. Weaver, T. Gardner, J. Babb (2009)
ACCF/SCAI/STS/MTS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization. CommentaryJournal of the American College of Cardiology, 53
M. Patel, G. Dehmer, J. Hirshfeld, Peter Smith, J. Spertus, F. Masoudi, R. Brindis, K. Beckman, C. Chambers, T. Ferguson, Mario Garcia, F. Grover, D. Holmes, L. Klein, M. Limacher, M. Mack, D. Malenka, Myung Park, M. Ragosta, J. Ritchie, G. Rose, Alan Rosenberg, R. Shemin, W. Weintraub, M. Wolk, Joseph Allen, P. Douglas, R. Hendel, E. Peterson (2009)
ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary RevascularizationCatheterization and Cardiovascular Interventions, 73
W Wijns, P Kolh, N Danchin (2010)
Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Eur Heart J, 20
J. Moses, M. Leon, J. Popma, P. Fitzgerald, D. Holmes, C. O'shaughnessy, R. Caputo, D. Kereiakes, David Williams, P. Teirstein, Judith Jaeger, R. Kuntz (2003)
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.The New England journal of medicine, 349 14
D. Morrison, G. Sethi, J. Sacks, W. Henderson, F. Grover, S. Sedlis, R. Esposito, K. Ramanathan, D. Weiman, J. Saucedo, T. Antakli, V. Paramesh, S. Pett, S. Vernon, V. Birjiniuk, F. Welt, M. Krucoff, W. Wolfe, J. Lucke, S. Mediratta, D. Booth, C. Barbiere, D. Lewis (2001)
Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft Surgery for Patients With Medically Refractory Myocardial Ischemia and Risk Factors for Adverse Outcomes With Bypass: A Multicenter, Randomized TrialJournal of the American College of Cardiology, 38
A. Ong, P. Serruys, F. Mohr, M. Morice, A. Kappetein, D. Holmes, M. Mack, M. brand, M. Morel, G. Es, J. Kleijne, J. Koglin, M. Russell (2006)
The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase.American heart journal, 151 6
A. Kappetein, K. Dawkins, F. Mohr, M. Morice, M. Mack, M. Russell, J. Pomar, P. Serruys (2006)
Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Insights from the SYNTAX run-in phase.European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 29 4
W. Wijns, Chairperson, Belgium, P. Kolh, N. Danchin, France, Carlo Di, Mario, K. Huber, S. James, Juhani Sweden, Jose Knuuti, Lopez-Sendon, Jean Spain, France Marco, L. Menicanti, Italy, M. Ostojić, Massimo Serbia, Charles Piepoli, Pirlet, Jose Belgium, Pomar, Nicolaus Spain, Reifart, Flavio Germany, Martin Ribichini, Paul Schalij, Sergeant, Patrick Belgium, S. Serruys, Silber, M. Germany, Sousa Uva, Humberto Sanmartin
Guidelines on Myocardial Revascularization the Task Force on Myocardial Revascularization of the European Society of Cardiology (esc) and the European Association for Cardio-thoracic Surgery (eacts) Developed with the Special Contribution of the European Association for Percutaneous Cardiovascular I
DA Morrison, G Sethi, J Sacks, W Henderson, F Grover, S Sedlis, R Esposito, K Ramanathan, D Weiman, J Saucedo (2001)
Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME)J Am Coll Cardiol, 38
R. Zahn, C. Hamm, S. Schneider, U. Zeymer, G. Richardt, M. Kelm, B. Levenson, T. Bonzel, U. Tebbe, G. Sabin, C. Nienaber, T. Pfannebecker, J. Senges, for Registry (2007)
The Sirolimus-eluting coronary stent in daily routine practice in Germany:Clinical Research in Cardiology, 96
Stuart Hoffman, J. Tenbrook, Michael Wolf, S. Pauker, D. Salem, J. Wong (2003)
A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes.Journal of the American College of Cardiology, 41 8
PW Serruys (2010)
SYNTAX left main: three-year outcomes from a prospective randomized trial of paclitaxel-eluting stents compared to bypass graft surgery in patients with left main coronary artery disease
R Zahn, CW Hamm, S Schneider, U Zeymer, G Richardt, M Kelm, B Levenson, T Bonzel, U Tebbe, G Sabin, CA Nienaber, T Pfannebecker, J Senges (2007)
The sirolimus-eluting coronary stent in daily routine practice in Germany: trends in indications over the years. Results from the prospective multi-center german cipher stent registryClin Res Cardiol, 96
FW Mohr (2010)
SYNTAX 3VD: three-year outcomes from a prospective randomized trial of paclitaxel-eluting stents compared to bypass graft surgery in patients with triple vessel coronary artery disease
J. Daemen, E. Boersma, M. Flather, J. Booth, R. Stables, Alfredo Rodríguez, G. Rodriguez-Granillo, W. Hueb, P. Lemos, P. Serruys (2008)
Long-Term Safety and Efficacy of Percutaneous Coronary Intervention With Stenting and Coronary Artery Bypass Surgery for Multivessel Coronary Artery Disease: A Meta-Analysis With 5-Year Patient-Level Data From the ARTS, ERACI-II, MASS-II, and SoS TrialsCirculation, 118
AP Kappetein (2010)
Optimal revascularization strategy in patients with three-vessel disease and/or left main disease. The 3-years outcomes of the SYNTAX trial
MR Patel, GJ Dehmer, JW Hirshfeld, PK Smith, JA Spertus (2009)
ACCF/SCAI/STS/AATS/AHA/ASNC 2009 appropriateness criteria for coronary revascularizationJ Am Coll Cardiol, 53
P. Serruys, M. Morice, A. Kappetein, A. Colombo, D. Holmes, M. Mack, E. Ståhle, T. Feldman, M. Brand, E. Bass, N. Dyck, Katrin Leadley, K. Dawkins, F. Mohr, Boston Scientif (2009)
Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.The New England journal of medicine, 360 10
Die koronare Bypassoperation gilt als Therapie der ersten Wahl in der Behandlung von Patienten mit Dreigefäßerkrankung und/oder linkskoronarer Hauptstammbeteiligung. Allerdings zeigt der klinische Alltag, dass an vielen europäischen Zentren inzwischen auch komplexe Formen der koronaren Herzerkrankung interventionell therapiert werden.
Clinical Research in Cardiology Supplements – Springer Journals
Published: Mar 24, 2011
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.